Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ANGLE PLC (DE:DWV)
FRANKFURT:DWV
Holding DE:DWV?
Track your performance easily
DWV Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.06 - €0.38
Previous Close€0.11
Volume0.00
Average Volume (3M)5.00K
Market Cap
€37.73M
Enterprise Value€23.64M
Total Cash (Recent Filing)£16.22M
Total Debt (Recent Filing)£4.55M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding322,641,668
10 Day Avg. Volume0
30 Day Avg. Volume5,000
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.11
Price to Sales (P/S)15.54
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.82Price Target Upside631.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ANGLE plc News
PremiumCompany Announcements
ANGLE plc Highlights Advances in Liquid Biopsy Technology
PremiumCompany Announcements
ANGLE plc Advances Cancer Treatment with Dual Analysis
PremiumCompany Announcements
ANGLE plc’s Breakthrough in Prostate Cancer CTC ProfilingPremiumCompany Announcements
ANGLE plc’s Parsortix System Hits 100 Publications MilestonePremiumCompany Announcements
ANGLE plc Pivots to Pharma Services with Promising Outlook
PremiumCompany Announcements
ANGLE Inks Deal for Advanced Cancer Sequencing Tech
PremiumCompany Announcements
ANGLE plc Advances Cancer Diagnostics with NuProbe Pact
PremiumCompany Announcements
ANGLE plc Clinches Deal with Recursion PharmaceuticalsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.76% Mutual Funds
― Other Institutional Investors
99.24% Public Companies and
Individual Investors
DWV FAQ
What was ANGLE PLC’s price range in the past 12 months?
ANGLE PLC lowest stock price was €0.06 and its highest was €0.38 in the past 12 months.
What is ANGLE PLC’s market cap?
Currently, no data Available
When is ANGLE PLC’s upcoming earnings report date?
ANGLE PLC’s upcoming earnings report date is Apr 24, 2025 which is in 161 days.
How were ANGLE PLC’s earnings last quarter?
ANGLE PLC released its earnings results on Sep 26, 2024. The company reported -€0.035 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.035.
Is ANGLE PLC overvalued?
According to Wall Street analysts ANGLE PLC’s price is currently Undervalued.
Does ANGLE PLC pay dividends?
ANGLE PLC does not currently pay dividends.
What is ANGLE PLC’s EPS estimate?
ANGLE PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ANGLE PLC have?
ANGLE PLC has 322,641,660 shares outstanding.
What happened to ANGLE PLC’s price movement after its last earnings report?
ANGLE PLC reported an EPS of -€0.035 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -29.268%.
Which hedge fund is a major shareholder of ANGLE PLC?
Currently, no hedge funds are holding shares in DE:DWV
---
ANGLE plc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€0.82 (631.25% Upside)
€0.82 (631.25% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.30%
12-Months-Change
Fundamentals
Return on Equity
-63.75%
Trailing 12-Months
Asset Growth
-17.88%
Trailing 12-Months
Company Description
ANGLE PLC
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology has the potential to treat and diagnose the various forms of cancer. The Parsortix system can capture and harvest (Circulating Tumor Cells)CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of the revenue is generated from Europe.
---
DWV Stock 12 Month Forecast
Average Price Target
€0.82
▲(631.25% Upside)
Technical Analysis
ANGLE plc
―
EKF Diagnostics Holdings
―
N4 Pharma
―
Avacta Group plc
―
Belluscura PLC
―
Best Analysts Covering DWV
1 Year
1 Year Success Rate
1/12 ratings generated profit
1 Year Average Return
-49.57%
reiterated a buy rating 2 months ago
Copying Odysseas Manesiotis's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -49.57% per trade.
---